A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer.
Breast Cancer Res Treat
; 136(1): 143-51, 2012 Nov.
Article
en En
| MEDLINE
| ID: mdl-22956006
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Calidad de Vida
/
Neoplasias de la Mama
/
Dexametasona
/
Quimioterapia Adyuvante
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Año:
2012
Tipo del documento:
Article